How much does a box of dabrafenib/dabrafenib cost in 2025?
Dabrafenib is a BRAF inhibitor targeted anti-cancer drug. It is mainly used to treat a variety of malignant tumor types with BRAF V600E mutations, including advanced melanoma, thyroid cancer, non-small cell lung cancer and certain brain tumors. Against the background of the rapid development of oncology medicine, dabrafenib has become an important treatment option for BRAF mutation-positive patients, especially when combined with MEK inhibitors such as trametinib, which can enhance treatment efficacy and delay the progression of drug resistance.

Due to its clear targeting effect in multiple cancer types, dabrafenib has been approved by regulatory agencies in many countries, including the USFDA, the EU EMA and the China State Food and Drug Administration. Domestically, dabrafenib has been included in the medical insurance catalog, and its use has benefited from the national drug negotiation policy, which has greatly reduced the burden on patients. Common specifications are 50mg 120 tablets and 75mg 120 tablets. The market price before medical insurance reimbursement is generally between 10,000 and 15,000 yuan. After being included in medical insurance, depending on the local policies of different provinces and cities, the actual payment by the patient may be only about 20% of the original price, which greatly improves the accessibility of the drug.
For patients who are not covered by medical insurance or need to find more cost-effective options on the market, overseas versions and generic drugs are also common options. Especially from channels such as Turkey and Laos, some original drugs of dabrafenib are sold for about RMB 7,000, while the price of generic drugs is more affordable, probably between 2,000 and 3,000 yuan. Of course, the specific price is still affected by exchange rate fluctuations and import costs.
It should be noted that no matter which channel you choose to purchase, you must ensure that the quality and source of the medicine are regular. It is recommended that patients obtain it through legally authorized medical channels and use the medicine under the guidance of a professional doctor to avoid unauthorized adjustment of dosage or frequency.
Reference materials:https://go.drugbank.com/drugs/DB08912
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)